Vaccine Development Challenges
There are currently no vaccines available for amoebic dysentery or shigellosis, although promising research is underway for Shigella. The complexity of various species and serotypes complicates the potential for effective cross-protection. Addressing dysentery requires a focus on clean water access and nutrition, as malnutrition significantly increases disease severity. Organizations are striving to eliminate deaths from diarrheal diseases by 2025, emphasizing the need for improved infrastructure and funding.In this clip
From this podcast
This Podcast Will Kill You
Ep 80 Dysentery loves a disaster
Related Questions